Browse by Phase
Phase 2 Clinical Trials
Phase 2 trials study whether a drug works in people with a specific disease or condition. These studies enroll 100–300 participants and also continue to evaluate safety.
Total Trials
1,071
Recruiting Now
1,071
Top Conditions in Phase 2
NCT03609398 Phase 2
Recruiting
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Condition
Rift Valley Fever
Enrollment
500 pts
Location
United States
Sponsor
U.S. Army Medical Research and
NCT04115163 Phase 2
Recruiting
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for t...
Condition
Metastatic Pancreatic Adenocarcinoma
Enrollment
67 pts
Location
United States
Sponsor
Anne Noonan
NCT04899687 Phase 2
Recruiting
Study of Dextromethorphan in OCD and Related Disorders
Condition
Obsessive-Compulsive Disorder
Enrollment
60 pts
Location
United States
Sponsor
Stanford University
NCT06205121 Phase 2
Recruiting
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidos...
Condition
Pulmonary Sarcoidosis
Enrollment
96 pts
Location
United States, Denmark, France
Sponsor
Molecure S.A.
NCT07071714 Phase 2
Recruiting
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies ...
Condition
Colorectal Cancer
Enrollment
200 pts
Location
China
Sponsor
Suzhou Suncadia Biopharmaceuti
NCT06885814 Phase 2
Recruiting
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients W...
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
30 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med
NCT06816914 Phase 2
Recruiting
Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, ...
Condition
Resectable Pancreatic Adenocarcinoma
Enrollment
84 pts
Location
Taiwan
Sponsor
Taichung Veterans General Hosp
NCT05232032 Phase 2
Recruiting
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem St...
Condition
Depressive Disorder, Major
Enrollment
112 pts
Location
United States
Sponsor
Mclean Hospital
NCT04700332 Phase 2
Recruiting
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Condition
Prostate Cancer
Enrollment
184 pts
Location
United States
Sponsor
Hoag Memorial Hospital Presbyt
NCT07122687 Phase 2
Recruiting
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as...
Condition
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Enrollment
170 pts
Location
China
Sponsor
Innovent Biologics (Suzhou) Co
NCT06400121 Phase 2
Recruiting
Apimostinel + Automated Neurocognitive Training for Depression
Condition
Depression
Enrollment
150 pts
Location
United States
Sponsor
Rebecca Price
NCT07301736 Phase 2
Recruiting
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With ...
Condition
Asthma
Enrollment
780 pts
Location
United Kingdom
Sponsor
Chiesi Farmaceutici S.p.A.
NCT01746836 Phase 2
Recruiting
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic...
Condition
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Enrollment
50 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06755684 Phase 2
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemother...
Condition
EGFR
Enrollment
60 pts
Location
China
Sponsor
Peng Zhang
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
NCT06717867 Phase 2
Recruiting
Long-Term PEA Safety Study
Condition
Healthy
Enrollment
200 pts
Location
Australia
Sponsor
RDC Clinical Pty Ltd
NCT07490587 Phase 2
Recruiting
To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on G...
Condition
Healthy Children
Enrollment
366 pts
Location
China, Malaysia
Sponsor
Min-Tze LIONG
NCT06699121 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Condition
Primary Sclerosing Cholangitis (PSC)
Enrollment
87 pts
Location
United States
Sponsor
LISCure Biosciences
NCT07400588 Phase 2
Recruiting
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Condition
Obese
Enrollment
50 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT05525273 Phase 2
Recruiting
Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Cranio...
Condition
Craniopharyngioma
Enrollment
25 pts
Location
Sweden
Sponsor
Eva Marie Erfurth, MD, PhD
NCT06402357 Phase 2
Recruiting
High Intensity Focused Ultrasound in Prostate Cancer
Condition
Prostate Cancer
Enrollment
25 pts
Location
United States
Sponsor
University of Florida
NCT04343157 Phase 2
Recruiting
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
Condition
Brain Metastases, Adult
Enrollment
60 pts
Location
United States
Sponsor
Jona Hattangadi-Gluth
NCT05771181 Phase 2
Recruiting
Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabiliz...
Condition
Colorectal Cancer
Enrollment
25 pts
Location
China
Sponsor
Fudan University
NCT07088419 Phase 2
Recruiting
"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
Condition
Mycoplasma Genitalium
Enrollment
40 pts
Location
United States
Sponsor
University of Washington
NCT05490719 Phase 2
Recruiting
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
39 pts
Location
China
Sponsor
Tianjin Medical University Can